NIH SBIR and STTR

The NIH SEED program serves as the gateway for small U.S. businesses to access the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant funding offered by the National Institutes of Health (NIH). It provides non-dilutive capital, primarily for early-stage research and development that holds high commercial promise. NIH SEED outlines eligibility criteria, application steps, and various support mechanisms—including technical/business assistance programs—to empower small businesses in health-tech, life sciences, diagnostics, digital health, and related fields. The program emphasizes commercialization readiness and bridges academic research and private sector impact. With set-asides exceeding a billion dollars annually, NIH SEED represents one of the largest early-stage grant sources for U.S. life science small businesses. It’s structured to help founders translate breakthrough science into meaningful products and markets, aligning with broader federal goals of innovation, economic development, and societal benefit.